Journal
CLINICAL SCIENCE
Volume 118, Issue 11-12, Pages 691-705Publisher
PORTLAND PRESS LTD
DOI: 10.1042/CS20090549
Keywords
fibrosis; hepatocellular carcinoma; ischaemia/reperfusion injury; non-alcoholic fatty liver disease (NAFLD); nuclear factor kappa B (NF-kappa B); regeneration
Categories
Funding
- Medical Research Council
- Wellcome Trust
- Royal College of Surgeons of Edinburgh
Ask authors/readers for more resources
NF-kappa B (nuclear factor kappa B) is a heterodimeric transcription factor that is constitutively expressed in all cell types and has a central role as a transcriptional regulator in response to cellular stress. In the present review, we discuss the role of NF-kappa B signalling in the maintenance of liver homoeostasis as well as in the pathogenesis of a wide variety of conditions affecting the liver, including viral hepatitis, steatohepatitis, cirrhosis and hepatocellular carcinoma. Much of the current knowledge of NF-kappa B signalling in the liver relates to the canonical pathway, the IKK [I kappa B (inhibitor of kappa B) kinase] complex and the RelA subunit. We explore the weaknesses of the experimental approaches to date and suggest that further work is needed to investigate in detail the discreet functions of each of the Rel subunits in liver physiology and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available